1. Home
  2. VANI vs CODA Comparison

VANI vs CODA Comparison

Compare VANI & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.43

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

HOLD

Current Price

$10.07

Market Cap

113.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
CODA
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
113.3M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
VANI
CODA
Price
$1.43
$10.07
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
166.8K
58.1K
Earning Date
05-14-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.62
EPS
N/A
0.23
Revenue
$4,000,000.00
$20,316,161.00
Revenue This Year
N/A
$18.28
Revenue Next Year
N/A
$12.62
P/E Ratio
N/A
$45.35
Revenue Growth
N/A
4.98
52 Week Low
$0.92
$7.80
52 Week High
$1.92
$18.00

Technical Indicators

Market Signals
Indicator
VANI
CODA
Relative Strength Index (RSI) 52.89 58.06
Support Level $1.26 $9.83
Resistance Level $1.55 $10.88
Average True Range (ATR) 0.08 0.34
MACD -0.00 0.02
Stochastic Oscillator 43.23 80.00

Price Performance

Historical Comparison
VANI
CODA

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: